Global Human Papillomavirus (HPV) Testing Markets to 2027 - The US Accounts for Over 29.5% of Global Market Size in 2020 - ResearchAndMarkets.com

The "Human Papillomavirus (HPV) Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Human Papillomavirus (HPV) Testing Market to Reach US$1.1 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Human Papillomavirus (HPV) Testing estimated at US$708.1 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 6.2% over the period 2020-2027.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 5.8% CAGR for the Period of 2020-2027

The Human Papillomavirus (HPV) Testing market in the U.S. is estimated at US$209 Million in the year 2020. The country currently accounts for a 29.51% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$189.3 Million in the year 2027 trailing a CAGR of 5.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR while Rest of European market (as defined in the study) will reach US$189.3 Million by the year 2027.

We bring years of research experience to this 6th edition of the report. The 108-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• Abbott Laboratories
• Agilent Technologies, Inc.
• Arbor Vita Corporation
• Becton, Dickinson & Company
• Cepheid, Inc.
• Daan Gene Co. Ltd.
• Diagcor Bioscience Incorporation Ltd.
• Enzo Biochem, Inc.
• F. Hoffmann-La Roche AG
• Fujirebio US, Inc.
• Greiner Bio-One International GmbH
• Hologic, Inc.
• Hybribio Limited
• Medical & Biological Laboratories Co. Ltd.
• Norgen Biotek Corporation
• Promega Corporation
• Qiagen N.V.
• Seegene, Inc.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• Zytovision GmbH

Key Topics Covered

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Human Papillomavirus (HPV) Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of COVID-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/g9dfdm

View source version on businesswire.com: https://www.businesswire.com/news/home/20200707005374/en/